Clarivo Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.51 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -59.61%
- Profit Growth 64.46%
- Ebitda 120.79%
- Net Worth -2.12%
- Total Assets -61.28%
About Clarivo Biosciences
Clarivo Biosciences Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 January 2018 (Seven years and one month 1 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.51 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Gupta and Aayush Gupta serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999PN2018PTC174099
-
Company No.
174099
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jan 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Clarivo Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Gupta
|
Director | 01-Jan-2018 | Current |
|
Aayush Gupta
|
Director | 01-Jan-2018 | Current |
Financial Performance of Clarivo Biosciences.
Clarivo Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 59.61% decrease. The company also saw a substantial improvement in profitability, with a 64.46% increase in profit. The company's net worth dipped by a decrease of 2.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clarivo Biosciences?
Unlock access to Clarivo Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Serabel Wellness LlpAayush Gupta is a mutual person
-
Qtanea Solutions Private Limited
Aayush Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clarivo Biosciences?
Unlock and access historical data on people associated with Clarivo Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clarivo Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clarivo Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
